Welcome to Chatterjee research lab


Our research group uses a combination of interdisciplinary approaches including chemical engineering, synthetic biology, systems biology, molecular biology, microbiology, metabolic engineering and computational biology to address key global challenges including medical and energy needs. We are interested in adopting an integrated mathematical modeling and experimental approach to investigate fundamental and medically relevant issues such as understanding the molecular mechanisms responsible for antibiotic and antiviral resistance, and for developing “next-generation smart antimicrobials” by rationally engineering novel therapeutics that target essential bacterial/viral genes in a potentially resistance-free manner. We study genetic regulatory networks that control propagation of infectious diseases, with the goal of discovering novel drug targets for therapy. Using synthetic biology tools we design, construct and engineer modular synthetic genetic devices that can achieve higher-order biological computation, for variety of biotechnological and bioenergy applications. To this end, we engineer biological parts such as transcription factors, promoter sequences, receptors, feedback loops, and regulatory RNA to build complex genetic networks that can be used to optimize cellular machinery for production of bio-fuels and pharmaceuticals, and for gene therapy applications. Using these genetic devices, we apply systems biology approaches to understand functioning of complex genetic networks and to build rules to manipulate such networks.

Read More

In the Spotlight


A new way of sequencing and delecting drug-resistant bacteria



We are developing a platform technology for fast, reliable, high-throughput and cost effective single molecule sequencing of nulciec acids.This kind of sequencing is an important step in the developement of new diagnostic tools for personalized medicine, as well as in rapid identification of DNA sequences that allow bacteria to develop drug resistance

This approach can potentially transform how we detect drug resistant pathogens in the clinical setting, will allow faster diagnostics and early detection of drug resistant strains that can prevent future spread of resistance, and will also reduce the cost of diagnostics.

Read more | The Denver post | ChBE

Chatterjee lab High School student gives TEDx Mile High Talk




Under the direction of Assistant Professor Anushree Chatterjee, lab high school student Logan Collins has been researching antiobiotic resistance. His work involved designing a gene sequence and delivery system to create fatal chaos in harmful bacteria while protecting beneficial bacteria. At the 2014 Intel International Science and Engineering Fair (ISEF), his project, “The Conjugative Plasmid RK2 as a Delivery System for Artificial AnatheriaH Genes: A Novel Synthetic Biology Alternative to Traditional Antibiotics,” won the microbiology Best of Category award, ISEF Patent and Trademark office Top award, as well as, the prestigious Dudley R. Herschbach SIYSS award.


Chatterjee lab students win NSF Awards and Honors


Chatterjee lab graduate students Colleen Courtney and Keesha Erickson won NSF awards and honors. Colleen was chosen to receive NSF Fellowship Award, while Keesha is the recipient of an NSF Honorable Mention.

Colleen is working on the design of smart antimicrobials to treat drug-resistant bacteria. Keesha is investigating fundamental mechanisms that allow bacteria to evolve to develop resistance to antimicrobials.